SEC 13F Intelligence

Bridger Management, LLC / BMRN

Bridger Management, LLC’s Biomarin Pharmaceutical Inc Position

Does Bridger Management, LLC own Biomarin Pharmaceutical Inc (BMRN)? Not currently — the last reported position was 143.0K shares worth $12M in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$12M
Q2 2023
Shares
143.0K
% of Portfolio
+4.13%
Quarters Held
5
position exited

Position History BMRN

Reported value by quarter
Q2 ’22: $17MQ2 ’22Q3 ’22: $9MQ3 ’22Q4 ’22: $15MQ4 ’22Q1 ’23: $14MQ1 ’23Q2 ’23: $12MQ2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2023143.0K$12M+4.13%
Q1 2023143.0K$14M+5.19%
Q4 2022142.4K$15M+5.98%
Q3 2022100.4K$9M+2.58%
Q2 2022207.8K$17M+3.88%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bridger Management, LLC’s full portfolio or all institutional holders of BMRN.